Gene · 3767
Papers4,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Simulation and Machine Learning Methods for Ion-Channel Structure Determination, Mechanistic Studies and Drug Design. | Front Pharmacol | 2022 | 35837274 | PubTator, text mining | PubMed |
| Micro-ribonucleic acid modulation with oxidative stress and inflammation in patients with type 2 diabetes mellitus - a review article. | Arch Med Sci | 2022 | 35832702 | PubTator, text mining | PubMed |
| Clinical presentation and long-term outcome of patients with KCNJ11/ABCC8 variants: Neonatal diabetes or MODY in the DPV registry from Germany and Austria. | Pediatr Diabetes | 2022 | 35822653 | PubTator, text mining | PubMed |
| MODY probability calculator utility in individuals' selection for genetic testing: Its accuracy and performance. | Endocrinol Diabetes Metab | 2022 | 35822264 | PubTator, text mining | PubMed |
| Early Postnatal Use of Glibenclamide in Permanent Neonatal Diabetes Secondary to Antenatally Diagnosed KJCN11 Mutation. | Horm Res Paediatr | 2022 | 35817008 | PubTator, text mining | PubMed |
| Knocking Out of CEACAM1 Can Reduce Oxidative Stress and Promote Cell Proliferation in the HPMVECs under Hypoxia. | J Immunol Res | 2022 | 35812245 | PubTator, text mining | PubMed |
| Centipede Venom: A Potential Source of Ion Channel Modulators. | Int J Mol Sci | 2022 | 35806107 | PubTator, text mining | PubMed |
| Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. | Eur J Heart Fail | 2022 | 35796209 | PubTator, text mining | PubMed |
| The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease. | Front Cardiovasc Med | 2022 | 35783865 | PubTator, text mining | PubMed |
| Ethnic disparities attributed to the manifestation in and response to type 2 diabetes: insights from metabolomics. | Metabolomics | 2022 | 35763080 | PubTator, text mining | PubMed |
| Rab35 GTPase positively regulates endocytic recycling of cardiac KATP channels. | Channels (Austin) | 2022 | 35754325 | PubTator, text mining | PubMed |
| Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis. | BMC Med | 2022 | 35754054 | PubTator, text mining | PubMed |
| A dual-activity topoisomerase complex regulates mRNA translation and turnover. | Nucleic Acids Res | 2022 | 35748872 | PubTator, text mining | PubMed |
| Kir4.2 Potassium Channels in Retinal Pigment Epithelial Cells In Vitro: Contribution to Cell Viability and Proliferation, and Down-Regulation by Vascular Endothelial Growth Factor. | Biomolecules | 2022 | 35740973 | PubTator, text mining | PubMed |
| Search for a time- and cost-saving genetic testing strategy for maturity-onset diabetes of the young. | Acta Diabetol | 2022 | 35737141 | PubTator, text mining | PubMed |
| Study of ten causal genes in Turkish patients with clinically suspected maturity-onset diabetes of the young (MODY) using a targeted next-generation sequencing panel. | Mol Biol Rep | 2022 | 35733065 | PubTator, text mining | PubMed |
| Metabolic cycles and signals for insulin secretion. | Cell Metab | 2022 | 35728586 | PubTator, text mining | PubMed |
| Global Registries in Congenital Hyperinsulinism. | Front Endocrinol (Lausanne) | 2022 | 35721728 | PubTator, text mining | PubMed |
| Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling. | Diabetes Metab Syndr Obes | 2022 | 35719247 | PubTator, text mining | PubMed |
| The role of cholesterol binding in the control of cholesterol by the Scap-Insig system. | Eur Biophys J | 2022 | 35717507 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3767/papers?page=32